+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction



Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction



International Journal of Radiation Oncology, Biology, Physics 12(2): 203-210



A series of experimental studies has been carried out to assess the relationship between the effectiveness of tumor control, normal tissue reaction and median survival following different radiation fractionation schedules on the solid tumor model 3924A in the ACI rat. The total radiation dose of 7500 rad and the dose per fraction of 250 rad were held constant. Tumor control and life expectancy improved with 250 rad given continuously as multiple fractions per day (MFD) (1, 2 and 3 fractions per day over 30-, 15- and 10-day periods, respectively). However, the maximum acute skin reaction surrounding the tumor was greater for MFD given continuously than for single daily fractions. We have also completed studies of the therapeutic effectiveness of MFD given intermittently at 11-day intervals. Tumor control following MFD given intermittently was comparable to that following the daily fraction schedule given continuously, and the normal tissue reaction was acceptable at a total radiation dose of 7500 rad. Experimental and clinical results in head and neck cancer indicate that large total radiation doses in the order of 7000 rad given as continuous MFD are associated with unacceptable normal tissue reaction. However, these clinical and experimental results also indicate that large total radiation doses can be given as MFD intermittently and effectively used in cancer management. The marked superiority of alternating chemotherapy and radiotherapy in obtaining a tumor cure rate of greater than or equal to 50% in our experimental system and the superiority of alternating chemotherapy and radiotherapy in extensive Hodgkin's disease (complete response rate--87%) over chemotherapy alone, radiotherapy alone, or the two modalities given together or as split course provides the clinical and experimental basis for the development of more effective protocols in the treatment of tumors responsive to chemotherapy and radiotherapy. A complete response rate of 78% in patients with head and neck cancer, and a complete response rate of 89% in patients with limited small cell carcinoma of the lung using alternating chemotherapy and radiotherapy indicate that it is now possible to proceed rapidly in clinical protocol design for these two additional tumors responsive to both chemotherapy and radiotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041390240

Download citation: RISBibTeXText

PMID: 3949571

DOI: 10.1016/0360-3016(86)90095-7


Related references

Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation. Cancer 45(11): 2793-2804, 1980

Solid tumor models for the assessment of different treatment modalities--XIV: the evaluation of host and tumor response to cyclophosphamide and radiation. International Journal of Radiation Oncology, Biology, Physics 5(9): 1461-1465, 1979

Solid tumor models for the assessment of different treatment modalities. XIX. Tumor cure rates and tumor control following sequential administration of radiation and cyclophosphamide. American Journal of Clinical Oncology 5(2): 209-220, 1982

Solid tumor models for the assessment of different treatment modalities: I. Radiation-induced changes in growth rate characteristics of a solid tumor model. Proceedings of the National Academy of Sciences of the United States of America 72(7): 2662-2666, 1975

Solid tumor models for the assessment of different treatment modalities. XXI. Comparison of different radiation dose schedules alone or in combination with cyclophosphamide. Cancer 51(6): 1012-1020, 1983

Solid tumor models for the assessment of different treatment modalities 2. combined chemo therapy radio therapy variation of time interval between time of administration of 5 fluoro uracil and radiation and its effect on the control of tumor growth. Cancer 44(2): 437-445, 1979

Solid tumor models for the assessment of different treatment modalities: VIII. The scheduling of treatment for a chemotherapeutically resistant experimental solid tumor. Cancer 43(4): 1201-1210, 1979

Solid tumor models for the assessment of different treatment modalities: XVI. Sequential combined modality (Cyclophosphamide-Radiation) therapy. Cancer 47(5): 860-869, 1981

Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy. Proceedings of the National Academy of Sciences of the United States of America 73(3): 818-822, 1976

Solid tumor models for the assessment of different treatment modalities: XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy. International Journal of Radiation Oncology, Biology, Physics 13(2): 217-224, 1987

Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models. Medical Physics 37(9): 5126-5137, 2010

Solid tumor models for the assessment of different treatment modalities: VI: Perturbations in the kinetics of tumor and host organ cellular regulation demonstrated by single and combined experimental therapy. Advances in Experimental Medicine and Biology 92: 677-757, 1977

Solid tumor models for the assessment of different treatment modalities part 6 perturbations in the kinetics of tumor and host organ cellular regulation demonstrated by single and combined experimental therapy. Morris, Harold P And Wayne E Criss (Ed ) Advances in Experimental Medicine And Biology, Vol 92 Morris Hepatomas Mechanisms Of Regulation Symposium Washington, D C , Usa, May 22-24, 1977 X+775p Illus Plenum Press: New York, N Y , Usa; London, England ISBN 0-306-32692-2: 677-757, 1978

Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy. Proceedings of the National Academy of Sciences of the United States of America 74(5): 1983-1987, 1977

Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapy. Cancer 54(3): 416-425, 1984